Surfactant therapy in neonates | Evidence, Current practice, and complications

The post outlines the Surfactant therapy for neonatal respiratory distress syndrome (RDS) or hyaline membrane disease (HMD). The following topics are covered

  1. Evidence
  2. Importance, 
  3. How it is done - the procedure
  4. Complications of surfactant administration in newborns.



about authors

Ajay Agade | DNB(Pediatrics), FNB(Pediatric Intensive Care), Fellowship in Pediatric pulmonology and LTV

Ajay is a Paediatric Intensivist, currently working in Pediatric Pulmonology & LTV at Great Ormond Street Hospital NHS, London

1 comment

  1. please leave your valuable comments

🩺 Help us refine this article — share corrections or additional information below. Let's elevate the accuracy of knowledge together! 💉💬

Cookies Consent

We use cookies from google to enhance browsing experience, analyze traffic, and personalize content. By continuing to use the site, you consent to use cookies. Privacy Policy

About cookies